$300.00
Tirzepatide is a highly purified, dual-targeted glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Supplied in a precise 70mg formulation, this synthetic peptide is engineered for advanced laboratory study and in-vitro research focusing on metabolic pathways, glycemic regulation, and receptor binding dynamics.
Product Specifications:
Formula: Tirzepatide (Dual GIP/GLP-1 receptor agonist)
Quantity: 70mg
Format: Lyophilized powder
Application: Strictly for laboratory and in-vitro research purposes. Not for human consumption.
